Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Year: 2001
Type: article
Source: PubMed
Authors: P Bonvini, W G An, A Rosolen, P Nguyen, J Trepel, A Garcia de Herreros, M Dunach, L M Neckers
Institution: National Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2113449833